| Identification | More | [Name]
Fenofibric acid | [CAS]
42017-89-0 | [Synonyms]
2-[4-(4-CHLOROBENZOYL) PHENOXY]-2'-METHYL PROPANOIC ACID
2-[4-(4-CHLOROBENZOYL)PHENOXY]-2-METHYLPROPANOIC ACID
2-[4-(4-CHLORO-BENZOYL)-PHENOXY]-2-METHYL-PROPIONIC ACID
FENOFIBRIC ACID
LABOTEST-BB LT00239222
SALOR-INT L498335-1EA
2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-propanoicaci
alpha1081
lf153
lf178acid
procetofenicacid
2-[4-(4-CHLORO-BENZOYL)-PHENOXY]-2-METHYL-PROPIONIC ACID (FENOFIBRIC ACID)
2-[4-(4-CHLOROBENBONYZOYL)PHENOXY)-2-METHYLPROPIONIC ACID
2-[4'-(p-Chlorobenzoyl)phenoxy]-2-methylpropionic acid
FENOFIBRATE ACID
A-1081 | [EINECS(EC#)]
255-626-9 | [Molecular Formula]
C17H15ClO4 | [MDL Number]
MFCD00792461 | [Molecular Weight]
318.75 | [MOL File]
42017-89-0.mol |
| Chemical Properties | Back Directory | [Appearance]
White to Off-White Solid | [Melting point ]
177-179°C | [Boiling point ]
486.5±35.0 °C(Predicted) | [density ]
1.286±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
powder | [pka]
3.09±0.10(Predicted) | [color ]
White to Off-White | [Usage]
Fenofibric acid, the active metabolite of fenofibrate. Increases Apolipoprotein A-Iediated High-Density Lipoprotein Biogenesis by enhancing transcription of ATP-Binding cassette transporter A1 gene in a liver X receptorependent manner | [BRN ]
2058973 | [CAS DataBase Reference]
42017-89-0(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xn,N | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . | [RIDADR ]
UN 3077 9 / PGIII | [WGK Germany ]
3 | [RTECS ]
UA2453000 | [HazardClass ]
9 | [PackingGroup ]
III | [HS Code ]
29189900 | [Toxicity]
LD50 oral in rat: 1242mg/kg |
| Hazard Information | Back Directory | [Chemical Properties]
White to Off-White Solid | [Uses]
DPP4 inhibitor, antidiabetic | [Uses]
Fenofibric acid, the active metabolite of fenofibrate. Increases Apolipoprotein A-Iediated High-Density Lipoprotein Biogenesis by enhancing transcription of ATP-Binding cassette transporter A1 gene in a liver X receptorependent manner | [Uses]
Fenofibric acid, the active metabolite of fenofibrate. Increases Apolipoprotein A-I–Mediated High-Density Lipoprotein Biogenesis by enhancing transcription of ATP-Binding cassette transporter A1 gene in a liver X receptor–dependent manner. | [Definition]
ChEBI: A monocarboxylic acid that is 2-methylpropanoic acid substituted by a 4-(4-chlorobenzoyl)phenoxy group at position 2. It is a metabolite of the drug fenofibrate. |
|
|